IPO Timeline
Broker Deadline
2026-06-25
Morning deadline
HKEX Deadline
2026-06-25
Noon deadline
Broker Results (T-2)
2026-06-26
Some brokers release in afternoon
Grey Market (T-1)
2026-06-29
Afternoon
HKEX Allotment (T-1)
2026-06-29
Evening
Registrar Allotment (T-1)
2026-06-29
Evening
Listing Day (T)
2026-06-30
First day of trading
Company Overview
| Stock Name | 江西生物 |
|---|---|
| Stock Code | 06915 |
| Company Full Name | 江西生物 |
| Industry | Healthcare |
| Principal Activities | 我们是中国最大的人用破伤风抗毒素（人用TAT）提供商和出口商，全产业链贯通的抗血清平台商，主要从事人用和兽用抗血清产品及兽用抗感染药物的研发、生产和销售。 |
| Listing Date | 2026-06-30 |
| Listing Rules Era | |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國 江西省吉安市 井岡山經濟技術開發區 火炬大道198號 |
| Business Address (Hong Kong) | 香港 銅鑼灣 勿地臣街1號 時代廣場二座31樓 |
| Place of Incorporation | 中国 |
| Listing Method | 全球发售 |
| Listing Board | Main Board |
| Website | www.jxswzp.cn |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | 卓佳证券登记有限公司，香港金钟道89号力宝中心1座31楼3101-3103室 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism B |
|---|---|
| Offer Price | To be extracted |
| Offer Price Range | HK$ 9.33 - 13.06 |
| Lot Size | 500 shares |
| Entry Threshold | HK$ 6,530 |
| Par Value | RMB 1.0 / shares |
| Offer Period | 2026-06-22 to 2026-06-25 |
| Global Offering Shares | 36,234,500 shares |
| HK Public Offer Shares (Initial) | 3,623,500 shares (10.0%) |
| Public Offer Lots (Initial) | 7,247lots (3,623lots, 3,624lots) |
| International Placing Shares (Initial) | 32,611,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 308,377,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 473,222,570 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 6,530 |
| 2 lots | 1,000 | HK$ 13,060 |
| 3 lots | 1,500 | HK$ 19,590 |
| 4 lots | 2,000 | HK$ 26,120 |
| 5 lots | 2,500 | HK$ 32,650 |
| 6 lots | 3,000 | HK$ 39,180 |
| 7 lots | 3,500 | HK$ 45,710 |
| 8 lots | 4,000 | HK$ 52,240 |
| 9 lots | 4,500 | HK$ 58,770 |
| 10 lots | 5,000 | HK$ 65,300 |
| 12 lots | 6,000 | HK$ 78,360 |
| 14 lots | 7,000 | HK$ 91,420 |
| 16 lots | 8,000 | HK$ 104,480 |
| 18 lots | 9,000 | HK$ 117,540 |
| 20 lots | 10,000 | HK$ 130,600 |
| 30 lots | 15,000 | HK$ 195,900 |
| 40 lots | 20,000 | HK$ 261,200 |
| 50 lots | 25,000 | HK$ 326,500 |
| 60 lots | 30,000 | HK$ 391,800 |
| 70 lots | 35,000 | HK$ 457,100 |
| 80 lots | 40,000 | HK$ 522,400 |
| 90 lots | 45,000 | HK$ 587,700 |
| 100 lots | 50,000 | HK$ 653,000 |
| 120 lots | 60,000 | HK$ 783,600 |
| 140 lots | 70,000 | HK$ 914,200 |
| 160 lots | 80,000 | HK$ 1,044,800 |
| 180 lots | 90,000 | HK$ 1,175,400 |
| 200 lots | 100,000 | HK$ 1,306,000 |
| 400 lots | 200,000 | HK$ 2,612,000 |
| 600 lots | 300,000 | HK$ 3,918,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 800 lots | 400,000 | HK$ 5,224,000 |
| 1,000 lots | 500,000 | HK$ 6,530,000 |
| 1,200 lots | 600,000 | HK$ 7,836,000 |
| 1,400 lots | 700,000 | HK$ 9,142,000 |
| 1,600 lots | 800,000 | HK$ 10,448,000 |
| 1,800 lots | 900,000 | HK$ 11,754,000 |
| 2,000 lots | 1,000,000 | HK$ 13,060,000 |
| 2,400 lots | 1,200,000 | HK$ 15,672,000 |
| 2,800 lots | 1,400,000 | HK$ 18,284,000 |
| 3,200 lots | 1,600,000 | HK$ 20,896,000 |
| 3,623 lots | 1,811,500 | HK$ 23,658,190 |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 2,877,157,410 - 4,027,403,620 |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | 盈利约人民币94.8百万元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | Loading... |
|---|
Underwriting Syndicate
Joint Sponsors (2)
中国国际金融香港证券有限公司 CE AEN894
招商证劵（香港）有限公司
Sponsor cum Overall Coordinator (2)
中国国际金融香港证券有限公司 CE AEN894
招商证劵（香港）有限公司
Joint Global Coordinators (3)
中国国际金融香港证券有限公司 CE AEN894
招商证劵（香港）有限公司
富途证券国际（香港）有限公司 CE AZT137
Joint Bookrunners (6)
中国国际金融香港证券有限公司 CE AEN894
招商证劵（香港）有限公司
富途证券国际（香港）有限公司 CE AZT137
国信证券（香港）经纪有限公司 CE AUI491
民银证券有限公司 CE APU820
裕承资产管理有限公司 CE AQW828
Joint Lead Managers (6)
中国国际金融香港证券有限公司 CE AEN894
招商证劵（香港）有限公司
富途证券国际（香港）有限公司 CE AZT137
国信证券（香港）经纪有限公司 CE AUI491
民银证券有限公司 CE APU820
裕承资产管理有限公司 CE AQW828
Capital Market Intermediaries (6)
中国国际金融香港证券有限公司 CE AEN894
招商证劵（香港）有限公司
富途证券国际（香港）有限公司 CE AZT137
国信证券（香港）经纪有限公司 CE AUI491
民银证券有限公司 CE APU820
裕承资产管理有限公司 CE AQW828
Service Providers
| Role | Institution |
|---|---|
| Legal Advisor to Company |
美迈斯律师事务所 北京市康达律师事务所 |
| Legal Advisor to Sponsors/Underwriters |
海问律师事务所有限法律责任合伙 竞天公诚律师事务所 |
| Auditor and Reporting Accountant | 德勤‧关黄陈方会计师行 |
| Industry Advisor | 弗若斯特沙利文（北京）咨询有限公司上海分公司 |
| Compliance Advisor | 百惠资本有限公司 |
| Receiving Banks |
招商永隆银行有限公司 中国农业银行股份有限公司香港分行 |
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 富策控股有限公司 | — | — | — | — | 6 months | 2026-12-30 |
Directors & Management
| Chairman | 敬玥 |
|---|---|
| Company Secretary | 敬瑞華、馮羨婷 |
執行董事 (4)
| # | Name | English Name | Type |
|---|---|---|---|
| 1 | 敬玥 | — | 執行董事 |
| 2 | 姚曉東 | — | 執行董事 |
| 3 | 李長青 | — | 執行董事 |
| 4 | 敬瑞華 | — | 執行董事 |
非執行董事 (2)
| # | Name | English Name | Type |
|---|---|---|---|
| 1 | 于愛蓮 | — | 非執行董事 |
| 2 | 肖長清 | — | 非執行董事 |
獨立非執行董事 (3)
| # | Name | English Name | Type |
|---|---|---|---|
| 1 | 鄒平學 | — | 獨立非執行董事 |
| 2 | 曾曉亮 | — | 獨立非執行董事 |
| 3 | 吳迪 | — | 獨立非執行董事 |
Major Shareholders
| Major Shareholders & Holdings | 前海天正（由海南至正全资拥有）持有66.05%股权 |
|---|
Offering Structure
Subscription Tiers
IPO Timeline
